Quick Takeaways
- Frank Torti has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $319,679,028.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Frank Torti and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | President and Vant Chair | $294,610,310 | -$82,039,460 | -22% | 31 Mar 2026 |
| IMVT | Immunovant, Inc. | Director | $25,068,718 | 07 Apr 2026 | ||
| ABUS | Arbutus Biopharma Corp | Director | 23 May 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|